Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Experimental immunity to the G1 domain of the proteoglycan versican induces spondylitis and sacroiliitis, of a kind seen in human spondylarthropathies
2003
Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial
2006 Standout
Anti-inflammatory activity of natural dietary flavonoids
2010 Standout
Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: Evaluation of a new scoring system
2003
Immunohistochemical analysis of hip arthritis in ankylosing spondylitis: Evaluation of the bone–cartilage interface and subchondral bone marrow
2006
Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT)
2005
Rheumatoid arthritis
2016 Standout
Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems
2004
Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: A clinical and magnetic resonance imaging study
2001
The elevated ratio of interferon gamma-/ interleukin-4-positive T cells found in synovial fluid and synovial membrane of rheumatoid arthritis patients can be changed by interleukin-4 but not by interleukin-10 or transforming growth factor beta
1999
Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling
2009
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
2009 Standout
Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor α in two patients with early disease and transforming growth factor β in three more advanced cases
2005
Animal models of inflammatory spinal and sacroiliac joint diseases
2003
Reductions in health-related quality of life in patients with ankylosing spondylitis and improvements with etanercept therapy
2005
Anti-tumour necrosis factor α therapy for ankylosing spondylitis: international experience
2002
Juvenile idiopathic arthritis
2007 Standout
Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti–tumor necrosis factor α agents
2007
Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis— cellularity correlates with the degree of enhancement detected by magnetic resonance imaging
2000
Enthesitis and ankylosis in spondyloarthropathy: What is the target of the immune response?
2000
European guidelines for the diagnosis and treatment of pelvic girdle pain
2008 Standout
Anti-TNF-alpha therapy in ankylosing spondylitis
2006
Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis
2004 Standout
Heterogeneity of CD4+ memory T cells: Functional modules for tailored immunity
2009
Six‐month results of a double‐blind, placebo‐controlled trial of etanercept treatment in patients with active ankylosing spondylitis
2003
Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab
2007
Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial
2006
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
2014 Standout
Randomized double‐blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (infliximab) versus placebo in active spondylarthropathy
2002
Pathogenesis of spondylarthropathies
1995
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
Anti–tumor necrosis factor α blockade in the treatment of juvenile spondylarthropathy
2005
Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis
2007
Ankylosing spondylitis
2007 Standout
First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis
2005
International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis
2003
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial
2002 Standout
Sustained response to tumor necrosis factor α–blocking agents in two patients with SAPHO syndrome
2002
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Rheumatic diseases: the effects of inflammation on bone
2005
Predominant cellular immune response to the cartilage autoantigenic G1 aggrecan in ankylosing spondylitis and rheumatoid arthritis
2003
Gene expression analysis of macrophages derived from ankylosing spondylitis patients reveals interferon‐γ dysregulation
2008
HLA–B27–restricted CD8+ T cell response to cartilage‐derived self peptides in ankylosing spondylitis
2005
Successful treatment of active ankylosing spondylitis with the anti–tumor necrosis factor α monoclonal antibody infliximab
2000
Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-? antagonists
2007
Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial
2003
Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis
2004
Colon mucosa of patients both with spondyloarthritis and Crohn's disease is enriched with macrophages expressing the scavenger receptor CD163
2004
Analysis of the CD8+ T cell response to the G1 domain of aggrecan in ankylosing spondylitis
2004
Treatment of Ankylosing Spondylitis by Inhibition of Tumor Necrosis Factor α
2002
The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis
2009 Standout
Effects of a novel tylophorine analog on collagen‐induced arthritis through inhibition of the innate immune response
2006 StandoutNobel
Are animal models useful for studying human disc disorders/degeneration?
2007 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Tumor Necrosis Factor-α Signaling in Macrophages
2010
Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label study
2002
Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: Results of a multicenter, randomized, double‐blind, placebo‐controlled magnetic resonance imaging study
2006
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
PATHOGENESIS OF RHEUMATOID ARTHRITIS
2001
RADIOLOGIC DIAGNOSIS AND PATHOLOGY OF THE SPONDYLOARTHROPATHIES
1998
Investigation of the relationship between the onset of arthritis and uveitis in genetically predisposed SKG mice
2015 StandoutNobel
The challenge of diagnosis and classification in early ankylosing spondylitis: Do we need new criteria?
2005 Standout
Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab.
2006
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
T‐cell receptor signaling and the pathogenesis of autoimmune arthritis: insights from mouse and man
2012 StandoutNobel
Differentiation of chronic sinus diseases by measurement of inflammatory mediators
2006 Standout
Ankylosing spondylitis: integrated clinical and physiological perspectives.
2003
Inflammatory and immune pathways in the pathogenesis of periodontal disease
2013 Standout
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
1996 Standout
Divergent T-cell cytokine patterns in inflammatory arthritis.
1994
Allicin: Chemistry and Biological Properties
2014 Standout
Cytokine Storm
2020 Standout
Clonally-related Immunoglobulin VH Domains and Nonrandom Use of DH Gene Segments in Rheumatoid Arthritis Synovium
1998
Infliximab in ankylosing spondylitis: a prospective observational inception cohort analysis of efficacy and safety.
2002
TNF‐mediated inflammatory disease
2007 Standout
Serum Creatine Kinase in Patients with Rheumatic Diseases
2000
Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies.
1995
Heterogeneity of Human CD4+T Cells Against Microbes
2016
Works of Jochen Sieper being referenced
IL-10 Is Excluded from the Functional Cytokine Memory of Human CD4+ Memory T Lymphocytes
2007
Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis
1995
Current perspectives in reactive arthritis
1993
Antigen-Dependent B Cell Differentiation in the Synovial Tissue of a Patient with Reactive Arthritis
1997
Antigen-dependent B cell differentiation in the synovial tissue of a patient with reactive arthritis.
1997